3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
von Hippel-Lindau Disease
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lung Neoplasms
1
Kidney Neoplasms
1
Hodgkin Disease
1
Carcinoma, Renal Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Medullary
1
Breast Neoplasms
1
Adenocarcinoma, Follicular
1
Interventions
Rituximab
49
fludarabine phosphate
32
Cyclophosphamide
30
Whole-Body Irradiation
26
Peripheral Blood Stem Cell Transplantation
25
Mycophenolic Acid
24
Tacrolimus
19
Cyclosporine
16
Dexamethasone
13
Busulfan
13
ibrutinib
12
Sirolimus
12
Bortezomib
11
Antilymphocyte Serum
11
Melphalan
10
Etoposide
10
Calcium Dobesilate
10
Methotrexate
8
Lenalidomide
8
Cyclosporins
8
idelalisib
7
Everolimus
6
Indium
5
Filgrastim
5
thymoglobulin
4
ibritumomab tiuxetan
4
carfilzomib
4
Vincristine
4
Prednisone
4
In Situ Hybridization, Fluorescence
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Waldenstrom Macroglobulinemia
×
tanespimycin
×
Clear all
No trials found.